GENEVA– A much larger tuberculosis drug-resistance problem exists than researchers previously thought. New global data on TB, published this month by the World Health Organization (WHO), highlight serious weaknesses in many national TB programs, increasing the potential for widespread TB drug resistance.

How did we reach this precarious state?

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.